NCT/Study#
NCT05471856 /
BI1480-0001
Phase Ia, first in human open label, dose escalation trial evaluating intravenous BI 1703880 in combination with intravenous ezabenlimab for treatment of advanced solid tumours
DISEASE GROUP:
Advanced Solid Tumors
current phase:
Phase I
STUDY STATUS:
Enrolling
Location:
Hackensack, NJ
For More information:
